| |
| Clinically
studied to support heart, brain, and skin health† |
|
| Dietary
Supplement |
|
| Product Numbers: 254021 |
|
| Product Quantities: 30
Wafers |
|
| Product Brand: Vitaline |
|
|
| Vitaline
CoQ10 is a clinically proven, high purity, natural CoQ10 product.† The
preferred form of CoQ10 for use in clinical research, it has
been the subject of over 25 studies and presentations.† NIH
funded studies have been recently completed, or are in progress,
at prestigious institutions including the University of California,
Harvard Medical School, Henry Ford Hospital, and Massachusetts
General Hospital. Produced to our exclusive and proprietary specifications,
Vitaline CoQ10 provides the highest purity CoQ10 available – anywhere.†
Vitaline CoQ10 has been the subject of clinical trials showing
benefits for heart and immune health, and has been the focus of
cutting edge research showing demonstrated benefits for neurological
health.† Vitaline CoQ10 has been designated an Orphan
Drug by the FDA.
|
|
|
| Recommendations: Adults
chew 1 wafer 1 to 2 times daily or as directed by your healthcare
practitioner. |
| Serving
Size: 1 Wafer |
Amount/Serving |
%DV |
|
| Total
Carbohydrate |
<1 |
g |
<1% |
|
| Vitamin
E (as dl-alpha tocopheryl acetate, d-alpha tocopheryl
acetate, and mixed tocopherols) |
300 |
IU |
1000% |
|
| CoEnzyme
Q10 (CoQ10) (ubiquinone 10) |
100 |
mg |
* |
|
| Percent
Daily Values (DV) are based on a 2,000 calorie diet. |
|
|
|
|
| *Daily
Value (DV) not established. |
|
|
| Other Ingredients: dextrose,
cocoa bean powder, fructose, cellulose, silicon dioxide, natural
flavors, calcium silicate, magnesium sulfate, and safflower
oil. |
Notes:
If pregnant, nursing, or taking prescription drugs, consult your healthcare
practitioner prior to use.
Proven to impact your health
in more than 30 trials and studies, Vitaline® CoQ10's patent-pending
formulation offers a fact base of efficacy and safety. Vitaline CoQ10
has been the CoQ10 of choice in NIH-funded research.
This product was made in an
FDA-registered Drug Establishment.
|
| |
| |
|
